Acesso livre
Acesso livre

Oncologia

Estudo controlado não randomizado | Impacto clínico da avaliação de margem intraoperatória na cirurgia conservadora de mama com o novo sistema orientado por pegulicianina fluorescente.

19 Mai, 2022 | 12:37h

Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence–Guided System: A Nonrandomized Controlled Trial – JAMA Surgery

 

Comentário no Twitter

 

M-A | Comparação da ablação por radiofrequência vs. crioablação para tumores renais T1.

19 Mai, 2022 | 12:35h

Comparison of Radiofrequency Ablation Versus Cryoablation For T1 Renal Tumors: An Evidence-Based Analysis of Comparative Outcomes – Frontiers in Oncology

Estudo de coorte | Desfechos de sobrevida associados com nefrectomia citorredutora em pacientes com carcinoma renal mestastático de células claras.

18 Mai, 2022 | 16:43h

Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma – JAMA Network Open

 

Comentário no Twitter

 

Estudo randomizado | Efeito da cistectomia radical assistida por robô com derivação urinária intracorpórea vs. cistectomia radical aberta sobre a morbidade e a mortalidade de 90 dias entre pacientes com câncer de bexiga.

17 Mai, 2022 | 12:11h

Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial – JAMA

Editorial: Robotic Surgery for Bladder Cancer – JAMA

 

Comentário no Twitter

 

[Comunicado de imprensa – ainda não publicado] Litíase biliar pode ser um forte preditor de câncer pancreático.

17 Mai, 2022 | 11:50h

Gallstone disease shown to be a strong predictor of pancreatic cancer – American Gastroenterology Association

Modulação adaptada ao risco por meio da de-intensificação de tratamentos oncológicos: classificação ESMO.

17 Mai, 2022 | 11:41h

Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification – Annals of Oncology

 

Comentário no Twitter

Sob licença de CC BY-NC-ND 4.0

M-A | Intervenções eletrônicas em saúde para pacientes com câncer de mama.

17 Mai, 2022 | 11:34h

Electronic Health Interventions for Patients With Breast Cancer: Systematic Review and Meta-Analyses – Journal of Clinical Oncology

Diretriz AUA/ASTRO | Câncer de próstata clinicamente localizado.

16 Mai, 2022 | 16:35h

Página principal: Clinically Localized Prostate Cancer: AUA/ASTRO Guideline – American Urological Association

Part I: Introduction, Risk Assessment, Staging and Risk-Based Management

Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up

Part III: Principles of Radiation and Future Directions

Conteúdos relacionados:

Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy – European Urology

Therapies for Clinically Localized Prostate Cancer: A Comparative Effectiveness Review – The Journal of Urology

High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial – The Lancet Oncology

German S3 Evidence-Based Guidelines on Focal Therapy in Localized Prostate Cancer: The First Evidence-Based Guidelines on Focal Therapy – Urologia Internationalis

Therapies for Clinically Localized Prostate Cancer – Agency for Healthcare Research and Quality

Radical prostatectomy versus deferred treatment for localised prostate cancer – Cochrane Library

Estudo randomizado | Tratamento com etirinotecano pegol para pacientes com câncer de mama metastático e metástases cerebrais.

16 Mai, 2022 | 16:21h

Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial – JAMA Oncology (gratuito por tempo limitado)

 

Comentário no Twitter

 

Tema especial | Detecção precoce multicâncer: aceleração do progresso por meio da colaboração internacional.

16 Mai, 2022 | 16:17h

Página principal: Multicancer Early Detection: Accelerating Progress Through International Collaboration

Multicancer early detection: International summit to Clarify the Roadmap

Multicancer early detection test: Preclinical, translational, and clinical evidence–generation plan and provocative questions

International perspectives on the development, application, and evaluation of a multicancer early detection strategy

Development and evaluation of safety and effectiveness of novel cancer screening tests for routine clinical use with applications to multicancer detection technologies

Evaluating the impact of multicancer early detection testing on health and economic outcomes: Toward a decision modeling strategy

Patient engagement and advocacy considerations in development and implementation of a multicancer early detection program

Industry engagement: Accelerating discovery, application, and adoption through industry partnerships

Conteúdos relacionados:

Opinion | Liquid biopsy: misplaced faith in early cancer detection?

Liquid Biopsy: Still Early Days for Early Detection

Opinion: New cancer test isn’t ready for prime time

Detection of Surgically Resectable Cancers with a Multi-analyte Blood Test

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.